Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study (vol 73, pg 2031, 2021): Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study (Clinical Infectious Diseases (2021) 73:11 (2031-2036) DOI: 10.1093/cid/ciab536)

Thomas Benfield, Jacob Bodilsen, Christian Brieghel, Zitta Barrella Harboe, Marie Helleberg, Claire Holm, Simone Bastrup Israelsen, Janne Jensen, Tomas Østergaard Jensen, Isik Somuncu Johansen, Stine Johnsen, Birgitte Lindegaard Madsen, Jens Lundgren, Christian Niels Meyer, Rajesh Mohey, Lars Pedersen, Henrik Nielsen, Stig Lønberg Nielsen, Niels Obel, Lars Haukali OmlandDaria Podlekareva, Birgitte Klindt Poulsen, Pernille Ravn, Haakon Sandholdt, Jonathan Starling, Merete Storgaard, Christian Søborg, Ole Schmeltz Søgaard, Torben Tranborg, Lothar Wiese, Hanne Rolighed Christensen

Abstract

An error appeared in the 1 December 2021 issue of the journal (Benfield et al. “Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study.” Clin Infect Dis; 73(11): 2031-2036. https://doi.org/10.1093/cid/ciab536). Currently the author Lars Pedersen’s name is listed as “Lars Møller Pedersen.” The author regrets this error.

Original languageEnglish
Publication date15 May 2022
Edition10
Volume74
Number of pages1
DOIs
Publication statusPublished - 15 May 2022
SeriesClinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN1058-4838

Fingerprint

Dive into the research topics of 'Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study (vol 73, pg 2031, 2021): Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study (Clinical Infectious Diseases (2021) 73:11 (2031-2036) DOI: 10.1093/cid/ciab536)'. Together they form a unique fingerprint.

Cite this